Muto CA. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections (HAIs) using active MRSA surveillance cultures (MSC)-three-year follow-up [ [3] . A total of 1564 patients (60%) had signs of rash among evaluable cases. Age-adjusted risks for meningitis (OR, 0.7; 95% CI, 0.6-0.9), encephalitis (OR, 0.5; 95% CI, 0.3-0.6), and death (OR, 0.3; 95% CI, 0.1-0.8) were also similarly decreased in patients with reported rash [4] .
A characteristic rash typically appears transiently in a diffuse maculopapular pattern at the height of febrile symptoms [4] [5] [6] . Few studies have examined the histopathological characteristics of rash lesions in WNV infection. In 1 case series, skin biopsy revealed superficial perivascular lymphocytic infiltrates seen commonly in viral exanthems [6] . Whether the development of rash in WNV infection reflects a functional immunoprotective response to circulating viral antigens requires further investigation and validation. Future surveillance activities should include prospective studies assessing features of rash that might account for its apparent favorable effect against severe disease and mortality in WNV disease. The authors referred to 2 matched cohort studies performed in critically ill patients by Blot et al. [2] and Garnacho et al. [3] . In both studies, the observed difference in mortality between patients with and without A. baumannii infection was not statistically significant. However, in the study by Blot et al. [2] , an ICU stay in excess of 5 days was found in patients with A. baumannii bacteremia (the median length of ICU stay for patients with and without A. baumannii bacteremia was 25 days and 20 days, respectively). This finding was statistically significant ( ). P p .04 García-Garmendia et al. [4] also performed a matched case-control study that compared the outcomes of patients hospitalized in the ICU with and without A. baumannii acquisition (defined as infection or colonization). We extracted the data from this study regarding the outcomes of the subsets of patients with A. baumannii infection (we excluded patients with A. baumannii colonization). The crude ICU mortality among patients with and without A. baumannii infection was 58% and 15%, respectively-a statistically significant difference ( )-P ! .001 resulting in an attributable mortality for A. baumannii infection of 43%. In addition, the median length of ICU stay was 13 days longer for patients with A. baumannii infection. This finding was also statistically significant ( ). P ! .001 Furthermore, Weingarten et al. [5] performed a matched case-control study that compared patients, most of whom were hospitalized in ICUs, with and without A. baumannii acquisition. We also extracted the relevant data from this study regarding the subsets of patients with A. baumannii infection. Although data regarding the attributable mortality for A. baumannii infection were not available, a statistically significant longer ICU stay was found among patients with A. baumannii infection.
We recently performed a systematic review of relevant matched cohort and casecontrol studies to evaluate the attributable mortality of A. baumannii infection among critically ill patients [6] . In the 6 matched cohort and case-control studies included in our review, we found that the attributable in-hospital mortality among patients with A. baumannii infection was 7.8%-23% and that the ICU mortality was 10%-43% [2] [3] [4] [7] [8] [9] . Although definitive statements regarding the attributable mortality of A. baumannii infection cannot be made from the available studies because of their methodological heterogeneity, we believe that the data from the relevant studies suggest that infection with A. baumannii may be associated with considerable attributable mortality and increased length of ICU stay.
